Topic

Insurance Approval

A collection of 6354 issues

How to Get Kineret (Anakinra) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kineret Covered in North Carolina Blue Cross Blue Shield of North Carolina typically requires prior authorization for Kineret (anakinra), including documented failure of conventional DMARDs and specialist attestation. The fastest path: Work with your rheumatologist to submit a comprehensive medical necessity letter documenting failed therapies and current
6 min read

Work With Your Doctor to Get Takhzyro (lanadelumab-flyo) Covered by Cigna in Georgia: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Takhzyro (lanadelumab-flyo) Covered by Cigna in Georgia Cigna requires prior authorization for Takhzyro (lanadelumab-flyo) with documented HAE types I/II, specialist involvement, and attack history. Work with an allergist or immunologist to submit PA documentation including C1-INH labs (<50% functional), C4 levels, and attack logs. If
6 min read

Complete Guide to Getting Evrysdi (Risdiplam) Covered by UnitedHealthcare in Texas: Prior Authorization Requirements and Appeals Process

Quick Answer: Getting Evrysdi Approved by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Evrysdi (risdiplam) with specific criteria: confirmed 5q SMA genetic mutation, baseline motor function assessment, and no concurrent Spinraza therapy. Submit via the UnitedHealthcare Provider Portal with genetic testing results and neurologist consultation. If denied, Texas law
5 min read

If Tavneos (Avacopan) Isn't Approved by Aetna in Georgia: Formulary Alternatives & Exception Strategies

Quick Answer: If Aetna denies Tavneos (avacopan) for ANCA-associated vasculitis in Georgia, first-line alternatives include rituximab with steroids or cyclophosphamide with steroids—both typically covered with prior authorization. Submit a formulary exception request via CVS Specialty (1-866-814-5506) with documentation showing why alternatives failed or caused intolerable side effects. If denied,
6 min read